Oncology

Browse Perspectives by Categories in Oncology
Advertisement

Oncology Conference Reporter

Emerging Biomarkers for Metastatic Castration-Resistant Prostate Cancer
conference reporter
By Andrew J. Armstrong, MD, MSc
After CDK4/6 Inhibition: Which Biomarkers Should Guide the Next Treatment Choice for HR+/HER2- Metastatic Breast Cancer?
conference reporter
By Komal Jhaveri, MD, FACP, FASCO
Digital Pathology in HR+/HER2- Early-Stage Breast Cancer
conference reporter
By Joseph A. Sparano, MD, FACP, FASCO
Investigational Agents and Recent Advances in Therapy for Myelofibrosis
conference reporter
By Raajit K. Rampal, MD, PhD

Latest in Oncology

Expert Roundtables Podcast: Next-Generation Tyrosine Kinase Inhibitors for ROS1-Positive Non–Small Cell Lung Cancer
Advanced ROS1-positive NSCLC

Expert Roundtables Podcast: Next-Generation Tyrosine Kinase Inhibitors for ROS1-Positive Non–Small Cell Lung Cancer

expert roundtables
By D. Ross Camidge, MD, PhD; Mark A. Socinski, MD; Heather Wakelee, MD, FASCO
Expert Roundtables Podcast: Individualizing Therapy for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors
Gastroenteropancreatic Neuroendocrine Tumors

Expert Roundtables Podcast: Individualizing Therapy for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors

expert roundtables
By Jennifer Chan, MD, MPH; Daniel M. Halperin, MD; Pamela L. Kunz, MD
Current Landscape and Future Directions in Anemia in MDS
Anemia in MDS

Current Landscape and Future Directions in Anemia in MDS

expert roundtables
By Andrew M. Brunner, MD; Guillermo Garcia-Manero, MD; Rami S. Komrokji, MD
Addressing Anemia in Patients With Myelofibrosis
Myelofibrosis

Addressing Anemia in Patients With Myelofibrosis

clinical topic updates
By John Mascarenhas, MD
Novel Combinations, Doublets, and Triplets in Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia

Novel Combinations, Doublets, and Triplets in Chronic Lymphocytic Leukemia

clinical topic updates
By Susan O’Brien, MD
Load More   
Advertisement